{"title":"系统性硬化症伴肺腺癌临床1例","authors":"V. Reshkova, R. Rashkov","doi":"10.35465/31.1.2023.pp95-101","DOIUrl":null,"url":null,"abstract":"We present a patient with 5 years systemic sclerosis with diffuse scin manifestations, capillaroscopic data to confirm diagnosis, elevated levels of ANA-antibodys, Anti-Sox-1, Anti-Ro-52 and Anti-Histoni in the course of lung adenocarcinoma (proven by fibrobronchoscopy and biopsy) and brain metastasis in consequence. From the clinical examination it is established diffuse scin manifestations, weakened vesicular respiration in right site of lung, astheno-adynamic syndrome, shortness of breath with usual physical exertion. From lung function testsр FVC is 58% anf FEV1 is 59%. The adenocarcinoma on a wide area in the right half of the lung and not indicated for surgical treatment. Patient was conducted 4 cours of chеmotherapy with Alimta + Cisplatin from marth 2016 г to jull 2016 year, 7 cours Docetaxel from februari 2017 year to septembre 2017 year, radiotherapy. One year later complaints appear from forget of words, hard reading and writing. Computed tomography (CT) shows intracranial tumor formation with heterogeneous structure in left frontal btain half – methastasis after lung adenocarcinoma. Was conducted operative removal of tumoral formation, postoperative radiotherapy and Depakin chrono 2 time for 500 мг daily. The treatment for systemic sclerosis was followed by 8 mg Methylprednisolon and 250 mg Cuprenil with good therapeutic effect.","PeriodicalId":380764,"journal":{"name":"Rheumatology (Bulgaria)","volume":"18 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Clinical case of systemic sclerosis in the course of lung adenocarcinoma\",\"authors\":\"V. Reshkova, R. Rashkov\",\"doi\":\"10.35465/31.1.2023.pp95-101\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"We present a patient with 5 years systemic sclerosis with diffuse scin manifestations, capillaroscopic data to confirm diagnosis, elevated levels of ANA-antibodys, Anti-Sox-1, Anti-Ro-52 and Anti-Histoni in the course of lung adenocarcinoma (proven by fibrobronchoscopy and biopsy) and brain metastasis in consequence. From the clinical examination it is established diffuse scin manifestations, weakened vesicular respiration in right site of lung, astheno-adynamic syndrome, shortness of breath with usual physical exertion. From lung function testsр FVC is 58% anf FEV1 is 59%. The adenocarcinoma on a wide area in the right half of the lung and not indicated for surgical treatment. Patient was conducted 4 cours of chеmotherapy with Alimta + Cisplatin from marth 2016 г to jull 2016 year, 7 cours Docetaxel from februari 2017 year to septembre 2017 year, radiotherapy. One year later complaints appear from forget of words, hard reading and writing. Computed tomography (CT) shows intracranial tumor formation with heterogeneous structure in left frontal btain half – methastasis after lung adenocarcinoma. Was conducted operative removal of tumoral formation, postoperative radiotherapy and Depakin chrono 2 time for 500 мг daily. The treatment for systemic sclerosis was followed by 8 mg Methylprednisolon and 250 mg Cuprenil with good therapeutic effect.\",\"PeriodicalId\":380764,\"journal\":{\"name\":\"Rheumatology (Bulgaria)\",\"volume\":\"18 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-05-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rheumatology (Bulgaria)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.35465/31.1.2023.pp95-101\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rheumatology (Bulgaria)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35465/31.1.2023.pp95-101","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
我们报告了一个5年系统性硬化症患者,弥漫性神经病变表现,毛细血管镜资料证实诊断,肺腺癌过程中ana抗体、Anti-Sox-1、Anti-Ro-52和Anti-Histoni水平升高(经纤维支气管镜检查和活检证实),结果发生脑转移。临床表现为弥漫性神经病变,右侧肺泡性呼吸减弱,乏力综合征,呼吸短促,常作体力消耗。肺功能测试显示FVC为58%,FEV1为59%。肺右半部分的大范围腺癌,不适合手术治疗。病人进行了4课chеmotherapy爱宁达+顺铂从2016年后гjull 2016年7课多烯紫杉醇从februari septembre 2017年2017年,放射治疗。一年后,抱怨出现在忘词、难读难写。CT显示肺腺癌后的左额叶颅内肿瘤结构不均匀,呈半转移。行手术切除肿瘤形成,术后放疗及Depakin chrono 2时间500次мг每日。治疗系统性硬化症后,甲泼尼松龙8 mg、库比尼250 mg,疗效良好。
Clinical case of systemic sclerosis in the course of lung adenocarcinoma
We present a patient with 5 years systemic sclerosis with diffuse scin manifestations, capillaroscopic data to confirm diagnosis, elevated levels of ANA-antibodys, Anti-Sox-1, Anti-Ro-52 and Anti-Histoni in the course of lung adenocarcinoma (proven by fibrobronchoscopy and biopsy) and brain metastasis in consequence. From the clinical examination it is established diffuse scin manifestations, weakened vesicular respiration in right site of lung, astheno-adynamic syndrome, shortness of breath with usual physical exertion. From lung function testsр FVC is 58% anf FEV1 is 59%. The adenocarcinoma on a wide area in the right half of the lung and not indicated for surgical treatment. Patient was conducted 4 cours of chеmotherapy with Alimta + Cisplatin from marth 2016 г to jull 2016 year, 7 cours Docetaxel from februari 2017 year to septembre 2017 year, radiotherapy. One year later complaints appear from forget of words, hard reading and writing. Computed tomography (CT) shows intracranial tumor formation with heterogeneous structure in left frontal btain half – methastasis after lung adenocarcinoma. Was conducted operative removal of tumoral formation, postoperative radiotherapy and Depakin chrono 2 time for 500 мг daily. The treatment for systemic sclerosis was followed by 8 mg Methylprednisolon and 250 mg Cuprenil with good therapeutic effect.